Verus Pharmaceuticals
In the following article, we will explore in detail the impact of Verus Pharmaceuticals on today's society. Since its appearance, Verus Pharmaceuticals has generated controversy and debate, attracting the attention of experts and people of all ages and interests. Over the years, Verus Pharmaceuticals has proven to have a significant impact on various aspects of everyday life, from the way we communicate to the way we consume information. In this article, we will discuss how Verus Pharmaceuticals has shaped our culture, influenced our decisions, and challenged our perceptions, as well as the possible future implications of its presence in our society.
 | This article includes a list of general references, but it lacks sufficient corresponding inline citations. (June 2019) |
 | |
| Company type | Privately held company |
|---|---|
| Industry | Pharmaceuticals |
| Founded | November 2002 |
| Headquarters | San Diego, California, United States |
Key people | Cam L. Garner, chairman & CEO Robert W. Keith, President & COO |
| Products | Twinject |
| Website | www.veruspharm.com |
Verus Pharmaceuticals was a privately held pharmaceutical company based in San Diego, California, USA. It was founded in November 2002 by three former Dura Pharmaceuticals executives, Bob Keith, Peter Schineller and Cam Garner, with an initial focus on the treatment of asthma, allergies and related diseases and conditions, specifically in children.
Verus is best known for its development and manufacturing of Twinject, the first (and currently only) two-dose epinephrine autoinjector. The Twinject was later licensed to Paladin Labs for manufacturing and distribution in Canada (released in September 2006.) The licence for manufacturing and distribution in Europe (and option for worldwide distribution) was sold to UCB.[citation needed]
Verus Pharmaceuticals was dissolved in March 2008 after selling its Twinject product to Sciele Pharma for $29 million.
In 2009, Verus filed a lawsuit against AstraZeneca and Tika Lakemedel, "seeking $1.3 billion on claims of fraud, breach of contract, and conversion."
See also
References
- ^ "Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB". BioSpace. Retrieved May 27, 2020.
- "Coming of Age: Pediatric Pharmaceuticals Get Some Attention From Legislators And Venture Capitalists", Healthcare Corporate Finance News, June 2005.
- Verus Pharmaceuticals official website
- Twinject official website
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |